Department of Clinical Pharmacy, Pharmacology and Toxicology, Zuyderland Medical Centre, Sittard-Geleen, The Netherlands.
Department of Clinical Pharmacy, Elkerliek Hospital, Helmond, The Netherlands.
BMJ Open. 2017 Nov 8;7(11):e016654. doi: 10.1136/bmjopen-2017-016654.
Delirium is an underdiagnosed, severe and costly disorder, and 30%-40% of cases can be prevented. A fully automated model to predict delirium (DEMO) in older people has been developed, and the objective of this study is to validate the model in a hospital setting.
Secondary care, one hospital with two locations.
Observational study.
The study included 450 randomly selected patients over 60 years of age admitted to Zuyderland Medical Centre. Patients who presented with delirium on admission were excluded.
Development of delirium through chart review.
A total of 383 patients were included in this study. The analysis was performed for delirium within 1, 3 and 5 days after a DEMO score was obtained. Sensitivity was 87.1% (95% CI 0.756 to 0.939), 84.2% (95% CI 0.732 to 0.915) and 82.7% (95% CI 0.734 to 0.893) for 1, 3 and 5 days, respectively, after obtaining the DEMO score. Specificity was 77.9% (95% CI 0.729 to 0.882), 81.5% (95% CI 0.766 to 0.856) and 84.5% (95% CI 0.797 to 0.884) for 1, 3 and 5 days, respectively, after obtaining the DEMO score.
DEMO is a satisfactory prediction model but needs further prospective validation with in-person delirium confirmation. In the future, DEMO will be applied in clinical practice so that physicians will be aware of when a patient is at an increased risk of developing delirium, which will facilitate earlier recognition and diagnosis, and thus will allow the implementation of prevention measures.
谵妄是一种未被充分诊断的严重且代价高昂的疾病,其中 30%-40%的病例可以预防。目前已经开发出一种用于预测老年人谵妄(DEMO)的全自动模型,本研究的目的是在医院环境中对该模型进行验证。
二级保健,一家医院有两个院区。
观察性研究。
该研究纳入了随机选择的 450 名年龄在 60 岁以上的入住 Zuyderland 医疗中心的患者。排除入院时即出现谵妄的患者。
通过病历回顾评估谵妄的发生情况。
本研究共纳入 383 名患者。分析在获得 DEMO 评分后 1、3 和 5 天内发生谵妄的情况。获得 DEMO 评分后 1、3 和 5 天内,1 天、3 天和 5 天的敏感度分别为 87.1%(95%CI 0.756 至 0.939)、84.2%(95%CI 0.732 至 0.915)和 82.7%(95%CI 0.734 至 0.893),特异性分别为 77.9%(95%CI 0.729 至 0.882)、81.5%(95%CI 0.766 至 0.856)和 84.5%(95%CI 0.797 至 0.884)。
DEMO 是一种令人满意的预测模型,但需要进一步前瞻性验证,通过面对面的谵妄确认。未来,DEMO 将应用于临床实践,以便医生能够及时识别患者发生谵妄的风险增加情况,从而促进早期识别和诊断,并实施预防措施。